Back to results
US 2008/0171709 A1Published application
Pharmaceutical Composition Comprising An Antiviral Agent, An Antitumoral Agent Or An Antiparasitic Agent, And An Active Agent Selected Among Carveol, Thymol, Eugenol, Borneol,And Carvacrol
AssigneeAdvanced Scientific Developments
InventorAdnane Remmal
Life of this patent
Estimating the term…
Abstract
The invention relates to a pharmaceutical composition comprising at least one first active therapeutic substance selected among carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone and beta-ionone, as well as isomers, derivatives and mixtures thereof, and comprising at least one second active therapeutic substance that is antitumoral. The invention is for use in the field of pharmaceutics.
Claims21
1-12. (canceled)
A pharmaceutical composition comprising:
- at least one first therapeutically active substance selected from the group consisting of carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, beta-ionone, and isomers, derivatives or mixtures thereof;
- and
- at least one second therapeutically active substance which is an antitumoral agent.
A kit comprising:
- at least one first container containing a first therapeutically active substance selected from the group consisting of carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, beta-ionone, and isomers, derivatives or mixtures thereof;
- and
- at least one second container containing a second therapeutically active substance which is an antitumoral agent.
A method for treating a tumor comprising the simultaneous or sequential administration to a patient having a tumor:
- at least one first therapeutically active substance selected from the group consisting of carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, beta-ionone and the isomers and derivatives and mixtures thereof;
- and
- at least one second therapeutically active substance which is an antitumoral agent.
Dependencies are inferred from the claim text.